Roche
2023
The pharmaceutical industry is one of Germany’s most important export industries. In recent years, the export of pharmaceutical products has seen above-average growth compared to the other export sectors. In addition, research and development play a prominent role for pharmaceutical companies.
Our new study for Roche focuses on these two aspects. It examines the extent to which the German pharmaceutical industry is particularly value-added intensive and innovative in its exports.
Compared to those in the other industries, German pharmaceutical exports are characterised by above-average value-added intensity and growth dynamics. This means that the export of pharmaceutical products (for example, worth one million euros) is linked to more domestic value added and jobs than the average German export of one million euros.
In an international comparison, the German pharmaceutical industry is shown to be one of the most important players on the world market and has been able to maintain its share of world exports in recent years.
In terms of research, the German pharmaceutical industry is losing ground on its international competitors:
For this detailed investigation of the German pharmaceutical industry in a national and international comparison, we relied on the available statistical data. This was then analysed with the help of the Prognos model landscape.
To the study (PDF in German)
Further information, in German (Roche website)
Project team: Dr Georg Klose, Dr Andreas Sachs, Johann Weiss
Latest update: 07.12.2023
Senior Project Manager
The Single Market Programme promotes the EU internal market in order to strengthen it, standardise it and make it more competitive. Prognos was involved in the mid-term evaluation of the programme.
To facilitate the transition to a climate-neutral economy, Prognos is supporting the European Commission in implementing the European Fair Transition Observatory (EFTO).
How do refugees with disabilities live in Germany? And how can they find work? We are addressing these issues in a study for the German Red Cross.
Prognos developed a methodology for Eurostat for regular data collection for the European Environmental Goods and Services Sector (EGSS).
We conducted a mid-term evaluation of the Programme Interreg Bavaria-Czech Republic 2021-2027 on behalf of the Bavarian State Ministry of Economic Affairs, Regional Development and Energy.
The Peer2Peer communities are a network of representatives from regional and national authorities in all EU Member States. Prognos recently took over the management of the Circular Economy Community.
As part of the Net-Zero Industry Act, we are working with our partners to conceptualise Net-Zero Acceleration Valleys for the European Commission.
On average, women receive significantly lower pensions than men. Our study for the GDV shows how they can strengthen their retirement provision.
Does your region have a future? The new Prognos Zukunftsatlas has answers. Exclusively published in the Handelsblatt on July 4.
On behalf of the Federal Ministry for the Environment, Prognos compiled the Green Tech Atlas 2025. The atlas provides a comprehensive overview of the cross-sectional environmental tech-nology and resource efficiency industries.
Prognos is one of the oldest economic research centres in Europe. Founded at the University of Basel, Prognos experts have been conducting research for a wide range of clients from the public and private sectors since 1959 – politically independent, scientifically sound.